Joshua Pinto
Fortune : 222 709 $ au 31/08/2026
Fortune : 222 709 $ au 31/08/2026
Joshua Pinto is currently President, Chief Executive Officer & Director at Neumora Therapeutics, Inc. since 2026.
Formerly, Dr. Pinto was Director at Metsera, Inc. from 2024 to 2025.
Education includes undergraduate studies at Centenary College of Louisiana and an MBA and a doctorate from McMaster University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/08/2026 | 167 450 ( 0,09 % ) | 222 709 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Directeur Général | 14/08/2026 |
| Sociétés | Poste | Fin |
|---|
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Centenary College of Louisiana
Centenary College of Louisiana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national